Clinical Trial Update: Welchol as Monotherapy for Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating Welchol (colesevelam) as monotherapy for type 2 diabetes mellitus were completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Welchol (colesevelam hydrochloride)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-01-22